Compatibility study In-vitro drug release Study of Solid Lipid Nanoparticle Based Transdermal Drug Delivery System for Rasagiline Mesylate

Prashant S. Wake; M. D. Kshirsagar

doi:10.5958/2231-5659.2017.00014.5

Asian Journal of Research in Pharmaceutical Sciences

ISSN

2231-5659 (Online)
2231-5640 (Print)

Submit Article

Compatibility study In-vitro drug release Study of Solid Lipid Nanoparticle Based Transdermal Drug Delivery System for Rasagiline Mesylate

Author(s): Prashant S. Wake, M. D. Kshirsagar

Email(s): Email ID Not Available

DOI: 10.5958/2231-5659.2017.00014.5

Address: Prashant S. Wake1*, Dr. M. D. Kshirsagar2
1Research Scholar, P. Wadhwani College of Pharmacy, Yavatmal (M. S.)
2Professor, P. Wadhwani College of Pharmacy, Yavatmal (M. S.)
*Corresponding Author

Published In: Volume - 7, Issue - 2, Year - 2017

View HTML

View PDF

ABSTRACT:
Transdermal drug delivery system (TDDS) is the dosage forms which deliver a therapeutically effective amount of drug across a patient’s skin. The Solid lipid nanoparticles were successfully developed for rasagiline mesylate. SLN dispersions were prepared by melt emulsification and solidification at low temperature method. Compatibility between Drug and polymer study by FTIR. DSC and in-vitro release profile were carried out. In the Transdermal Drug Delivery System, Formulations F1-F9 was prepared by solvent casting method using 1.5%, 2.5% and 3.5% of HPMC K4M and 20%, 30% and 40% (w/w of dry polymer) of PEG 400. The formulation F5 was selected as the promising formulation on the basis of cumulative % drug release. The cumulative % drug diffused of F5 was found to be 89.55 ± 1.983. Further, the patch was found to be free of skin irritation. From the results stability study it can be concluded that the patches can be stored at 40°C and 75% RH without any significant stability problems. The formulation satisfied all the pharmaceutical parameters of transdermal films and appears to be promising.

Keywords:

Cite this article:
. Compatibility study In-vitro drug release Study of Solid Lipid Nanoparticle Based Transdermal Drug Delivery System for Rasagiline Mesylate. Asian J. Res. Pharm. Sci. 2017; 7(2): 92-96. doi: 10.5958/2231-5659.2017.00014.5

Cite(Electronic):
. Compatibility study In-vitro drug release Study of Solid Lipid Nanoparticle Based Transdermal Drug Delivery System for Rasagiline Mesylate. Asian J. Res. Pharm. Sci. 2017; 7(2): 92-96. doi: 10.5958/2231-5659.2017.00014.5 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2017-7-2-6

Analytical Method Development and Validation for the Estimation of Sacubitril and Valsartan in Combined Pharmaceutical Dosage Forms by RP-HPLC

Author(s): Y. Phalguna, Noor Jahan, Indraja N, Satheesh Kumar G;

DOI: 10.5958/2231-5659.2018.00003.6 Access: Open Access Read More

Development and Validation of Spectrophotometric Method for Determination of Azelaic Acid

Author(s): Kadam T.V. , Darekar A.B., Gondkar S.B., Saudagar R.B.

DOI: 10.5958/2231-5659.2015.00014.4 Access: Open Access Read More

Current Scenario of Global and Indian Pharmaceutical Marketing and Management

Author(s): Darekar A. B. , Zope Janhavi S. , Saudagar R. B.

DOI: 10.5958/2231-5659.2016.00013.8 Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available
DOI: 10.52711/2231-5659